Process for manufacturing vaccines

Details for Australian Patent Application No. 2006263965 (hide)

International Classifications

Event Publications

24 January 2008 PCT application entered the National Phase

PCT publication WO2007/000343 Priority application(s): WO2007/000343

10 June 2010 Section 223 Application Allowed

GlaxoSmithKline Biologicals S.A. The time in which to request examination has been extended to 27 May 2010. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

10 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

13 September 2012 Application Accepted

Published as AU-B-2006263965

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.